Solara Active Pharma Sciences Ltd Share Price

Pharmaceuticals

NSE: SOLARA Small Cap ISIN: INE624Z01016

As on 13 June 2026 at 01:06 IST

₹613.85

+ 33.15

(5.71%)

Sell Buy

Over 1 Month

10.28%

Over 6 Months

-2.95%

Over 1 Year

13.20%

Over 3 Years

78.52%

Solara Active Pharma Sciences Ltd Summary

Close ₹580.70

Open ₹565.50

High ₹616

Low ₹565.50

Volume 9,82,658

Net Turnover (in Cr) ₹58.83

52Wk High ₹734.40

52Wk Low ₹422

52Wk High / Low

422

734.40

Solara Active Pharma Sciences Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹2,770.63

EPS (TTM) -

Book Value (BV) 263.80

Div. Yield -

P/E (TTM) -382.43

Price/Book Value 2.20

Delivery % 18.28 %

Face Value 10

Key Ratios

PE Ratio -

PB Ratio 1.88

EV to Sales 2.18

PEG Ratio -

ROA -0.06

ROE -

Debt-Equity 0.89

Net Profit Margin -0.08

Operating Profit Margin 16.59

Solara Active Pharma Sciences Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,292.08	1,294.29	1,466.36	1,288.36	1,645.65
Total Expenses	1,291.54	1,592.54	1,511.18	1,375.97	1,424.15
Profit Before Tax	0.54	-488.42	-44.82	-91.10	221.50
Profit After Tax	0.54	-566.96	-22.25	-58.29	221.35
Operating Profit After Depreciation	115.35	-193.14	45.24	-12.33	305.98

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	1,191.12	1,265.50	1,340.02	1,331.80	1,356.29
Total Non Current Assets	1,503.11	1,550.21	1,711.74	1,705.68	1,555.95
Total Current Assets	728.73	800.75	1,187.54	1,239.28	1,057.63
Total Assets	2,231.84	2,350.96	2,899.28	2,944.96	2,613.58
Total Shareholder's Fund	1,094.24	933.91	1,500.21	1,524.87	1,588.53

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	212.82	108.87	156.25	-242.03	155.46
Net Cash Used In Investing Activities	-36.83	-3.51	-81.14	-242.85	-106.30
Net Cash Used In Financing Activities	-180.48	-105.65	-112.76	333.57	92.49

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,292.90	1,294.29	1,465.95	1,287.10	1,645.29
Total Expenses	1,293.98	1,592.98	1,510.73	1,375.27	1,424.33
Profit Before Tax	-1.08	-488.33	-44.78	-91.66	220.96
Profit After Tax	-1.08	-566.87	-22.21	-58.56	220.96
Operating Profit After Depreciation	113.73	-192.72	45.28	-12.90	305.43

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	1,184.52	1,258.70	1,333.22	1,325	1,349.49
Total Non Current Assets	1,496.50	1,555.95	1,704.08	1,697.57	1,552.18
Total Current Assets	728.60	790.65	1,190.87	1,239.87	1,057.99
Total Assets	2,225.10	2,346.60	2,894.95	2,937.44	2,610.17
Total Shareholder's Fund	1,096.21	937.42	1,503.13	1,527.05	1,592.79

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	212.80	110.95	156.17	-241.77	154.44
Net Cash Used In Investing Activities	-36.83	-4.66	-81.13	-243.08	-105.25
Net Cash Used In Financing Activities	-180.48	-106.52	-112.76	333.59	92.50

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	387.29	349	313.54	319.15	273.01
Total Expenses	329.63	311.66	278.81	262.13	227.64
Profit Before Tax	9.60	-17.43	-10.10	10.52	-2.10
Profit After Tax	9.60	-17.43	-10.10	10.52	-2.10
Operating Profit after Depreciation	62.35	37.34	35.22	58	51.32

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	387.29	349	313.54	319.15	273.01
Total Expenses	329.74	311.65	278.79	262.12	230.42
Profit Before Tax	9.73	-17.42	-10.08	10.53	-4.88
Profit After Tax	9.73	-17.42	-10.08	10.53	-4.88
Operating Profit after Depreciation	61.97	37.35	35.24	58.01	48.54

Solara Active Pharma Sciences Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 558.80

S2 536.90

S3 508.30

Pivot 587.40

R1 609.30

R2 637.90

R3 659.80

Moving Average

20 SMA 553.73

50 SMA 514.72

100 SMA 499.55

200 SMA 548.03

Solara Active Pharma Sciences Ltd Corporate Actions

Solara Active Pharma Sciences Ltd

₹3.0/Share

Announcement Date 18 Aug 2021

Record Date 20 Aug 2021

Div Yield 30%

AGM Date: 25 Aug 2021

Solara Active Pharma Sciences Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 21, 2021 to August 25, 2021 (both days inclusive) for the purpose of Payment of Dividend & 4th Annual General Meeting (AGM) of the Company to be held on August 25, 2021. We wish to inform you that 4th Annual General Meeting ('AGM') of the Company will be held over video conference/ other audio-visual means on Wednesday, August 25, 2021 at 10:30 a.m (IST) in compliance with the circulars issued by the Ministry of Corporate Affairs ('MCA'), Government of India and Securities and Exchange Board of India ('SEBI') and all other applicable laws. As informed by the Company on May 6, 2021, Board of Directors has recommended a final dividend of Rs. 3.00 per share. The Record Date for the purpose of Final Dividend for FY 2020-2021 will be Friday, August 20, 2021. Final Dividend once approved by the Members in the ensuing AGM will be paid within 30 days from the date of approval. Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, Register of Members and Share Transfer Books of the Company will remain closed from August 21, 2021 to August 25, 2021 (both days inclusive). (As Per BSE Announcement Dated on 28.07.2021) We wish to inform you that the Fourth Annual General Meeting (AGM) of the Company was held on Wednesday August 25 2021 through Video Conferencing. Please find attached the summary of proceedings of the AGM as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. (As Per BSE Announcement Dated on 8/25/2021 7:21:15 AM) Voting Results as required under Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and Scrutinizers Report on voting results as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. (As Per BSE Announcement Dated on 8/26/2021 10:25:50 AM) Solara Active Pharma Sciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As per BSE Announcement Dated on 27/8/2021)

AGM Date: 25 Aug 2022

We wish to inform about Newspaper Advertisements for 5th Annual General Meeting of the Company to be held through Video Conferencing (VC)/Other Audio-Visual Means (OAVM) on August 25, 2022. We wish to inform you that the Register of Members and Share transfer books shall remain closed from August 18, 2022, to August 25, 2022 (both days inclusive) for the purpose of 5th Annual General Meeting of the company for the Financial Year 2021-22. With reference to the above subject, please find enclosed herewith the newspaper advertisement published in Business Standard (English Edition) and Pratahkal (Marathi Edition) on August 2, 2022, regarding notice of 5th Annual General Meeting and e-Voting information. (As Per BSE Announcement Dated on 02.08.2022) This is in continuation to our letter dated August 4, 2022, informing about the cessation of directorship of Mr. Kartheek Raju (DIN: 02921819) as a Director of the Company pursuant to his resignation on August 3, 2022. Consequent to above, Resolution No. 3 of the Notice of Fifth Annual General Meeting scheduled to be held on August 25, 2022, to resolved that 'To appoint a director in place of Mr. Kartheek Raju Chintalapati (holding DIN 02921819) who retires by rotation and being eligible offers himself for reappointment as Non-Executive Director of the Company' has become redundant and stands withdrawn. (As Per BSE Announcement dated on 10.08.2022) We wish to inform you that the Fifth Annual General Meeting ('AGM') of the Company was held on Thursday, August 25, 2022, through Video Conferencing. Please find attached the summary of proceedings of the AGM as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement Dated on 25.08.2022) Submission of Voting Results of the 5th Annual General Meet ing Ref: Reg. 44 of SEBI (Listing Obligat ions and Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement Dated on 27.08.2022) Solara Active Pharma Sciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here (As Per BSE Announcement Dated 29.08.2022)

AGM Date: 15 Sep 2023

AGM 15/09/2023 Proceedings of the 6th Annual General Meeting (AGM) of the Company. (As Per BSE Announcement Dated on 15/09/2023)

AGM Date: 20 Sep 2024

AGM 20/09/2024 Newspaper advertisement before dispatch of notice of the Seventh Annual General Meeting (As Per BSE Announcement Dated on 26.08.2024) Solara Active Pharma Sciences Limited has informed the Exchange regarding Proceedings of Seventh Annual General Meeting held on Friday, September 20, 2024 at Bangalore, commenced at 10:00 A.M. and concluded at 11:10 A.M. (As per BSE Announcement Dated on 20/09/2024)

AGM Date: 25 Sep 2025

AGM 25/09/2025 Solara Active Pharma Sciences Limited - Proceedings of the Eighth Annual General Meeting (As Per BSE Announcement Dated on 25.09.2025) Solara Active Pharma Sciences Limited has intimated the Stock exchange regarding the Voting Results and Scrutinizer''s Report of the 8th Annual General Meeting. (As Per BSE Announcement Dated on: 29/09/2025)

Solara Active Pharma Sciences Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Solara Active Pharma Sciences Ltd Top Mutal Funds Invested

Fund Name	AUM
Aditya Birla SL Manufacturing Equity Fund	0.62%
Aditya Birla SL Flexi Cap Fund	0.09%
Bandhan BSE Healthcare Index Fund	0.08%
Motilal Oswal BSE 1000 Index Fund	0.01%

Solara Active Pharma Sciences Ltd News

Solara Active Pharma Sciences allots 2,200 equity shares under ESOP

15 May 2026, 03:08 pm

Solara Active Pharma spurts after reporting turnaround Q4 perfromance

Solara Active Pharma Sciences soared 15.20% to Rs 584.85 after the company reported consolidated net profit to Rs 9.60 crore in Q4 FY26 compared with net loss of Rs 2.10 crore in Q4 FY25.

15 May 2026, 02:28 pm

Solara Active Pharma Sciences declare Quarterly Result

On 15 May 2026

09 May 2026, 12:29 pm

Solara Active Pharma Sciences schedules board meeting

On 24 March 2026

20 Mar 2026, 09:32 am

Solara Active Pharma Sciences schedules board meeting

On 6 February 2026

31 Jan 2026, 10:40 am

Solara Active Pharma Sciences Ltd Stock Analysis

Annual revenue for Solara Active Pharma Sciences Ltd decreased by 0.11% to ₹1,292.90 crore in FY 2025 from ₹1,294.29 crore in FY 2024.
Annual Net Profit for Solara Active Pharma Sciences Ltd decreased by 99.81% to ₹-1.08 crore in FY 2025 from ₹-566.87 crore in FY 2024.
Promoter Shareholding in Solara Active Pharma Sciences Ltd remains unchanged by 0.00% in the most recent quarter, from 42% in March 2026 to 42% in May 2026.
Solara Active Pharma Sciences Ltd delivered a 1-year return of 13.20% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Solara Active Pharma Sciences Ltd share price moved up by 5.71% from its previous close of INR ₹580.70. The latest Solara Active Pharma Sciences Ltd share price is INR ₹613.85.
Solara Active Pharma Sciences Ltd share price today has been at a low of 581.05 and a high of 619.90. Over the past 52 weeks, the Solara Active Pharma Sciences Ltd share price has seen a low of 422 and a high of 734.40.